Share the post "JHS Svendgaard Laboratories announced Financial Results Q1 2024"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 28.67 % in the past year, substantial increase in net sales/revenue by 13.02 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -76.07 %, Marginal decrease of -76.71% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for JHS Svendgaard Laboratories Limited. Profit dropped by -79.25 % Year to Year, JHS Svendgaard Laboratories Limited’s profitability dropped by -16.36 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -80.00 % Year to Year. EPS decreased by -20 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 19.028 Cr | Rs. 21.663 Cr | Rs. 24.484 Cr | + 13.02 % | + 28.67 % |
Expenses | Rs. 22.05 Cr | Rs. 20.83 Cr | Rs. 22.51 Cr | + 8.07 % | + 2.09 % |
Operating Profit | Rs. -3.02 Cr | Rs. 0.83 Cr | Rs. 1.97 Cr | + 137.35 % | + 165.23 % |
OPM % | -15.87 % | 3.83 % | 8.05 % | + 4.22 % | + 23.92 % |
Other Income | Rs. 1.337 Cr | Rs. 1.374 Cr | Rs. 0.32 Cr | -76.71 % | -76.07 % |
Interest | Rs. 0.23 Cr | Rs. 0.13 Cr | Rs. 0.12 Cr | -7.69 % | -47.83 % |
Depreciation | Rs. 1.74 Cr | Rs. 1.9 Cr | Rs. 1.97 Cr | + 3.68 % | + 13.22 % |
Profit before tax | Rs. -3.65 Cr | Rs. 0.17 Cr | Rs. 0.2 Cr | + 17.65 % | + 105.48 % |
Tax % | -17.05 % | 520.11 % | 416.08 % | -104.03 % | + 433.13 % |
Net Profit | Rs. -3.03 Cr | Rs. -0.75 Cr | Rs. -0.63 Cr | + 16 % | + 79.21 % |
EPS in Rs | Rs. -0.4 | Rs. -0.1 | Rs. -0.08 | + 20 % | + 80 % |
Today, we’re looking at JHS Svendgaard Laboratories Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 28.67 %. However, it did see a marginal increase of 13.02 % from the previous quarter. Expenses ticked up slightly by 8.07 % quarter-on-quarter, aligning with the annual rise of 2.09 %. Operating profit, while up 165.23 % compared to last year, faced a quarter-on-quarter increase of 137.35 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 23.92 %, but an expansion of 4.22 % sequentially. Other income fell by -76.71 % compared to the last quarter, despite an annual decline of -76.07 %. Interest expenses dropped significantly by -7.69 % from the previous quarter, yet the year-over-year decrease remains at a moderate -47.83 %. Depreciation costs climbed by 3.68 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 13.22 %. Profit before tax grew annually by 105.48 % but saw an increase from the preceding quarter by 17.65 %.
Tax expenses as a percentage of profits increased slightly by 433.13 % compared to last year, with a more notable quarter-on-quarter decrease of -104.03 %. Net profit rose by 79.21 % year-on-year but experienced a 16 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 80 % but a quarterly rise of 20 %. In summary, JHS Svendgaard Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 19.028 Cr | Rs. 21.663 Cr | Rs. 24.484 Cr | + 13.02 % | + 28.67 % |
Expenses | Rs. 22.05 Cr | Rs. 20.83 Cr | Rs. 22.51 Cr | + 8.07 % | + 2.09 % |
Operating Profit | Rs. -3.02 Cr | Rs. 0.83 Cr | Rs. 1.97 Cr | + 137.35 % | + 165.23 % |
Net Profit | Rs. -3.03 Cr | Rs. -0.75 Cr | Rs. -0.63 Cr | + 16 % | + 79.21 % |
EPS in Rs | Rs. -0.4 | Rs. -0.1 | Rs. -0.08 | + 20 % | + 80 % |
In reviewing JHS Svendgaard Laboratories Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 28.67 % year-on-year growth, however, there was a minor increase of 13.02 % from the previous quarter. Expenses rose by 2.09 % compared to the previous year, with a 8.07 % increase quarter-on-quarter. Operating Profit surged by 165.23 % annually, and saw a 137.35 % increase from the last quarter.
Net Profit showed yearly increase of 79.21 %, and experienced a 16 % increase from the previous quarter. Earnings Per Share (EPS) rose by 80 % annually, however rose by 20 % compared to the last quarter. In essence, while JHS Svendgaard Laboratories Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.